35.04 USD
↘ 0.09 (0.24%)PRE MARKET (AS OF 07:54 AM EDT)
Roivant Sciences Ltd. Common Shares
ROIVNASDAQ • USD
Market: OPEN
Roivant Sciences Ltd. Common Shares (ROIV) trades at $35.04 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 6, 2026.
Open?$36.15
High?$36.15
Low?$35.04
Prev. Close?$35.12
Volume?35
Avg. Volume?5.4M
VWAP?$36.01
Rel. Volume?0.00x
Bid / Ask
Bid?$33.48 × 100
Ask?$37.05 × 100
Spread?$3.57
Midpoint?$35.27
Valuation & Ratios
Market Cap?25.4B
Shares Out?722.4M
Float?371.0M
Float %?51.8%
P/E Ratio?N/A
P/B Ratio?5.60
EPS?-$0.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Employees
721
Market Cap
25.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-01
Address
7TH FLOOR, 50 BROADWAY
LONDON, SW1H 0DB
Phone: 441-295-5950
LONDON, SW1H 0DB
Phone: 441-295-5950
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?100
Momentum?50
Short Sent.?29
Piotroski F-Score?3/9Weak
Altman Z-Score?37.17Safe
Confidence?60%Moderate
Short InterestHigh
Short % of Float?9.89%Elevated
Short Interest?36.7M
Days to Cover?7.7
Free Float371.0M
Avg Daily Volume4.8M
Settlement Date2026-07-15
Financial Health
Current Ratio?18.37Strong
Quick Ratio?18.37Strong
Cash Ratio?5.05Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?5.60FAIR▾
Peers100
S&P33
P/S?3,071.18HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-18.7CHEAP▾
S&P97
EV/Sales?2,899.36HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-6.6%WEAK▾
S&P10
ROA?-5.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-758558000
Enterprise Value?$23.9B
Fundamentals ratios updated end of day